Traded Dec 19, 2025 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.
Traded Nov 21, 2025 · Filed Nov 24, 2025
A Brady director sold $78K of Brady shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$78,330
Shares × reported transaction price
4 days after results of Nov 17, 2025, 90 days before results of Feb 19, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −3.1% | +1.0% | −4.0% |
| 30 days | −0.9% | +2.3% | −3.2% |
| 90 days | +13.3% | +1.1% | +12.3% |
| 180 days | +8.7% | +11.2% | −2.5% |
Past results only. Not a forecast.
Traded Dec 19, 2025 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.
Traded Dec 19, 2025 · filed 3 days laterNot under a reported trading plan
The CFO of Brady sold $334K of Brady shares. The filing does not indicate a pre-arranged trading plan.
Traded Dec 19, 2025 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.